NEUROCRINE BIOSCIENCES INC Operating Leases, Rent Expense, Sublease Rentals
NEUROCRINE BIOSCIENCES INC (NBIX) reported Operating Leases, Rent Expense, Sublease Rentals of $300.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2018-04-30
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for the quarter ending 2018-03-31 was $300.00K, a 50.00% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for the quarter ending 2017-09-30 was $0.00.
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for the quarter ending 2017-06-30 was $0.00.
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for the quarter ending 2017-03-31 was $600.00K, a 45.45% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for fiscal 2016 was $600.00K, a 45.45% decline from fiscal 2015.
- NEUROCRINE BIOSCIENCES INC operating leases, rent expense, sublease rentals for fiscal 2015 was $1.10M.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 1 month | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month | Operating Leases, Rent Expense, Sublease Rentals 9 month | Operating Leases, Rent Expense, Sublease Rentals 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $300.00K 10-Q · filed 2018-04-30 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $600.00K 10-Q · filed 2017-11-01 | $600.00K derived: sum of 4 quarters · filed 2017-11-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $600.00K 10-Q · filed 2017-08-03 | $600.00K derived: sum of 3 quarters · filed 2017-08-03 | $600.00K derived: sum of 4 quarters · filed 2017-08-03 | |
| 2017-03-31 | $600.00K 10-Q · filed 2017-05-09 | $600.00K derived: sum of 2 quarters · filed 2017-05-09 | $600.00K derived: sum of 3 quarters · filed 2017-05-09 | $100.00K derived: sum of 4 quarters · filed 2017-05-09 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | -$500.00K derived: sum of 3 quarters · filed 2017-02-14 | $600.00K 10-K · filed 2017-02-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$500.00K derived: sum of 2 quarters · filed 2016-11-02 | $600.00K 10-Q · filed 2016-11-02 | $600.00K derived: sum of 4 quarters · filed 2016-11-02 | |
| 2016-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $600.00K 10-Q · filed 2016-08-03 | $600.00K derived: sum of 3 quarters · filed 2016-08-03 | $400.00K derived: sum of 4 quarters · filed 2016-08-03 | |
| 2016-03-31 | $1.10M 10-Q · filed 2016-05-05 | $1.10M derived: sum of 2 quarters · filed 2016-05-05 | $900.00K derived: sum of 3 quarters · filed 2016-05-05 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$200.00K derived: sum of 2 quarters · filed 2016-02-11 | $1.10M 10-K · filed 2016-02-11 | ||
| 2015-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $1.10M 10-Q · filed 2015-10-29 | |||
| 2015-06-30 | $1.30M 10-Q · filed 2015-07-29 | ||||
| 2011-09-30 | $100.00K 10-Q · filed 2012-07-31 | ||||
| 2010-12-31 | $600.00K 10-Q · filed 2013-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |